コーパス検索結果 (left1)
通し番号をクリックするとPubMedの該当ページを表示します
1 Cockcroft-Gault estimated renal function improved over t
2 -0.76 +/- 16.5, CRMSE = 16.5, r2 = 0.69; (2) Cockcroft-Gault, delta GFR = 9.56 +/- 14.9, CRMSE = 17.7
4 th modification of diet in renal disease and Cockcroft-Gault equations displayed the lowest performan
5 , Modification of Diet in Renal Disease, and Cockcroft-Gault equations, and we evaluated baseline fac
6 he relationship between hemoglobin level and Cockcroft-Gault creatinine clearance (CrCl) and to estim
7 vels (i.e., age, sex, creatinine levels, and Cockcroft-Gault estimated creatinine clearance, current
10 ed with that of established formulas such as Cockcroft-Gault, Modification of Diet in Renal Disease,
11 cific eGFR equations were compared with both Cockcroft-Gault creatinine clearance (CrCl) and measured
13 te clearance, 8.2% by MDRD equation, 7.7% by Cockcroft-Gault equation, and 14.8% by creatinine cleara
14 Gault equation adjusted for BSA, followed by Cockcroft-Gault equation, and CKD-EPI equation, while th
15 lified MDRD equation), Cockcroft-Gault (CG), Cockcroft-Gault corrected for GFR (CG-GFR), and other eq
19 cretion than subjects in the original cohort Cockcroft Gault, which led to biased and highly variable
20 24-hour urinary creatinine clearance (CrCl), Cockcroft-Gault (CG), and previously reported creatinine
21 mated by four methods: 100/serum creatinine, Cockcroft-Gault equation, creatinine clearance from 24-h
22 diet in renal disease estimated GFR (eGFR), Cockcroft-Gault estimated creatinine clearance, and endo
23 e MDRD 1, MDRD 2 (simplified MDRD equation), Cockcroft-Gault (CG), Cockcroft-Gault corrected for GFR
24 ine (Scr) by using two prediction equations [Cockcroft-Gault and that from the Modification of Diet i
26 static glomerular filtration rate formulas (Cockcroft and Gault, modification of diet in renal disea
28 ) on midstream urine sample; and reduced GFR-Cockcroft-Gault estimated GFR (abnormal: <60 ml/min per
29 ia or macroalbuminuria) or renal impairment (Cockcroft-Gault estimated creatinine clearance <60 ml/mi
30 m; eGFR, 98+/-19 and 63+/-12 mL/min/1.73 m; Cockcroft-Gault estimated creatinine clearance, 125+/-33
31 ween-group changes in baseline-adjusted mean Cockcroft-Gault GFR at month 12 (primary efficacy end po
32 the Cooperative Cardiovascular Project, mean Cockcroft-Gault creatinine clearance was 55 +/- 24 ml/mi
33 eference values, whereas only 40% and 60% of Cockcroft-Gault- and MDRD-based GFRs, respectively, were
35 FR (OR [MDRD] 2.0 [95% CI 1.0 to 4.2] or OR [Cockcroft-Gault] 1.9 [95% CI 0.9 to 3.9]), and creatinin
37 as estimated using the recently recalculated Cockcroft-Gault (GFR-CGc) and the simplified Modificatio
39 tion of Diet in Renal Disease (MDRD) and the Cockcroft-Gault (CG) equations as compared with measured
40 ations with standardized creatinine, and the Cockcroft-Gault (CG) formula as compared with (125)I-iot
42 ase (MDRD) study formula for the GFR and the Cockcroft-Gault estimate of creatinine clearance, were e
43 l function over time estimated with both the Cockcroft-Gault and Chronic Kidney Disease Epidemiology
44 s the first test for GFR evaluation, but the Cockcroft-Gault (CG) equation is still commonly used in
45 f kidney disease (62 [69%] studies), but the Cockcroft-Gault formula (22 [24%] studies) and Modificat
46 than serum creatinine, GFR (estimated by the Cockcroft-Gault [GFRCG] and Modification of Diet in Rena
48 er 1.73 m(2) from baseline estimated [by the Cockcroft-Gault equation] glomerular filtration rate [eG
52 creatinine clearance (CrCl) derived from the Cockcroft-Gault formula (normal, > or = 90 ml/min; mild,
53 l 6-variable equation and better than in the Cockcroft-Gault equation, even when the latter was corre
54 ce of 30-69 mL/min (calculated by use of the Cockcroft-Gault equation) or Cumulative Illness Rating S
55 calculated creatinine clearance based on the Cockcroft-Gault equation (147.9 +/- 50.2 vs 109.1 +/- 32
56 cted by measured creatinine clearance or the Cockcroft-Gault formula was 86.6% and 84.2%, respectivel
57 ment with MR imaging, which outperformed the Cockcroft-Gault and MDRD formulas, adds less than 10 min
58 timate creatinine clearance according to the Cockcroft-Gault and Jelliffe formulas were available fro
59 ing serum creatinine levels according to the Cockcroft-Gault and modification of diet in renal diseas
60 ne clearance (CrCl) were estimated using the Cockcroft-Gault (C-G) and Modification of Diet in Renal
61 the placebo group during follow-up using the Cockcroft-Gault (P < .001) and CKD-EPI (P = .007) equati
64 nine clearance was also calculated using the Cockcroft-Gault equation and estimated glomerular filtra
69 ory of creatinine clearance (CrCl) using the Cockcroft-Gault formula (CrCl < 45, 45 to 59, and > or =
70 posttransplant and also calculated using the Cockcroft-Gault method at the transplant evaluation; at
71 GFR calculation algorithms: the best was the Cockcroft-Gault equation adjusted for BSA, followed by C
72 underestimated iothalamate GFR, whereas the Cockcroft Gault formula underestimated it when it was <1
74 rular filtration rate was estimated with the Cockcroft-Gault, Chronic Kidney Disease Epidemiology Col
75 enal function of trial participants with the Cockcroft-Gault, Modification of Diet in Renal Disease (
76 Estimated GFR (eGFR) was calculated with the Cockcroft-Gault, Modification of Diet in Renal Disease S
77 of medication dosing discordance relative to Cockcroft-Gault CrCl or measured GFR for 8 commonly pres
78 (TICS-m) and estimated kidney function using Cockcroft-Gault creatinine clearance (CCl), Modification
80 than the calculated creatinine clearance via Cockcroft-Gault and estimated glomerular filtration rate
81 at 1 year were compared in patients in whom Cockcroft-Gault and CKD-EPI provided concordant or disco
82 illation with chronic kidney disease in whom Cockcroft-Gault suggested a dose reduction of dabigatran
84 mated glomerular filtration rate (eGFR) with Cockcroft-Gault (C-G) and Modification of Diet in Renal